JANX Janux Therapeutics, Inc. - Common Stock
$17,30
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$12–$35
21% of range
Analystenbewertung
BUY
26 analysts
Kursziel
$37
+114% upside
P/E (TTM)
-9.5
ROE
-11.7%
Nettogewinnmarge
-1136.2%
JANX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$17.30
Marktkapitalisierung
$1.04B
P/E (TTM)
-9.5
EPS (TTM)
$-1.83
Umsatz (TTM)
$10M
Dividendenrendite
—
ROE
-11.7%
Verschuldungsgrad
—
52W-Spanne
$12 – $35
JANX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$10M
2020-12-31
→
2025-12-31
EPS
$-1.83
2021-12-31
→
2025-12-31
Freier Cashflow
$-83M
2021-12-31
→
2025-12-31
Margen
-1136.2%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
JANX
Peer-Median
P/E (TTM)
-9.5
—
P/S (TTM) (K/V (TTM))
104.5
12.8
P/B (K/B)
1.1
3.4
Price / FCF (Kurs / FCF)
-12.5
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
JANX
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-1576.7%
—
Net Profit Margin (Nettogewinnmarge)
-1136.2%
-294.4%
ROA
-11.0%
-31.3%
ROE
-11.7%
-38.1%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
JANX
Peer-Median
Current Ratio (Liquiditätsgrad)
39.0
10.9
Quick Ratio
38.7
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
JANX
Peer-Median
Revenue YoY (Umsatz YoY)
-5.5%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
5.1%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
JANX
Peer-Median
JANX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
26 Analysten
- Starker Kauf 9 34,6%
- Kauf 12 46,2%
- Halten 4 15,4%
- Verkauf 1 3,8%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
16 Analysten · 2026-08-17
Median
$32.00
Mittelwert
$37.06
Jetzt
$17.30
Tief
$14.00
Hoch
$75.00
Median-Ziel
$32.00
+85,0%
Mittelwert-Ziel
$37.06
+114,2%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.09%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.35 | $-0.39 | 0.04% |
| 31. März 2026 | $-0.39 | $-0.54 | 0.15% |
| 31. Dezember 2025 | $-0.51 | $-0.66 | 0.15% |
| 30. September 2025 | $-0.39 | $-0.63 | 0.24% |
| 30. Juni 2025 | $-0.55 | $-0.48 | -0.07% |
| 31. März 2025 | $-0.38 | $-0.40 | 0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | — |
| ODTX | — | — | — | — | — | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| ANNX | $750M | -3.7 | — | — | -100.7% | — |
| SLDB | $445M | -2.8 | — | — | -79.5% | — |
| GERN | $845M | -10.2 | -60.2% | — | -34.4% | — |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | — |
| CADL | $310M | -7.8 | — | — | -53.7% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $10M | $11M | $8M | $9M | $4M | $0 | |
| R&D Expense | $126M | $68M | $55M | $53M | $26M | $3M | |
| SG&A Expense | $42M | $41M | $26M | $22M | $10M | $2M | |
| Operating Income | $-158M | $-99M | $-73M | $-67M | $-33M | $-5M | |
| Other Non-op | $44M | $30M | $15M | $4M | $257.0K | $-2M | |
| Income Tax | $0 | $0 | $0 | · | · | · | |
| Net Income | $-114M | $-69M | $-58M | $-63M | $-33M | $-7M | |
| EPS (Basic) | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 | · | |
| EPS (Diluted) | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 | · | |
| Shares (Basic) | 61,966,999 | 53,751,480 | 44,016,283 | 41,469,631 | 23,530,252 | 233,726 | |
| Shares (Diluted) | 61,966,999 | 53,751,480 | 44,016,283 | 41,469,631 | 23,530,252 | · | |
| EBITDA | $-158M | $-99M | $-73M | $-67M | $-33M | · |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $52M | $431M | $19M | $51M | $36M | $8M | |
| Short-term Investments | $914M | $595M | $325M | $276M | $339M | $0 | |
| Receivables | $0 | · | $0 | $0 | $0 | $8M | |
| Prepaid Expense | $9M | $8M | $5M | $5M | $2M | $249.0K | |
| Current Assets | $976M | $1.03B | $349M | $332M | $377M | $16M | |
| PP&E (Net) | $4M | $5M | $7M | $7M | $1M | $155.0K | |
| PP&E (Gross) | $11M | $10M | $10M | $8M | $2M | $176.0K | |
| Accum. Depreciation | $7M | $5M | $3M | $972.0K | $131.0K | $21.0K | |
| Other Non-current Assets | $3M | $3M | $3M | $1M | $392.0K | $0 | |
| Total Assets | $1.00B | $1.06B | $380M | $364M | $380M | $16M | |
| Accounts Payable | $5M | $4M | $2M | $2M | $2M | $428.0K | |
| Accrued Liabilities | $18M | $12M | $7M | $8M | $4M | $751.0K | |
| Current Liabilities | $25M | $17M | $13M | $17M | $13M | $3M | |
| Capital Leases | $20M | $21M | $23M | $25M | $0 | $0 | |
| Total Liabilities | $45M | $39M | $36M | $43M | $13M | $9M | |
| Common Stock | $60.0K | $59.0K | $46.0K | $42.0K | $41.0K | $1.0K | |
| Retained Earnings | $-351M | $-238M | $-169M | $-110M | $-47M | $-15M | |
| AOCI | $4M | $2M | $665.0K | $-2M | $-270.0K | $0 | |
| Stockholders' Equity | $957M | $1.02B | $344M | $321M | $366M | $-15M | |
| Liabilities + Equity | $1.00B | $1.06B | $380M | $364M | $380M | $16M | |
| Shares Outstanding | 60,384,283 | 59,064,606 | 46,252,440 | 41,616,260 | 41,243,137 | 1,046,599 |
Cashflow 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $33M | $20M | $17M | $7M | $72.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-82M | $-44M | $-51M | $-43M | $-17M | $-4M | |
| CapEx | $1M | $359.0K | $2M | $6M | $1M | $0 | |
| Investing Cash Flow | $-301M | $-258M | $-41M | $58M | $-341M | $0 | |
| Financing Cash Flow | $5M | $713M | $60M | $500.0K | $387M | $12M | |
| Free Cash Flow | $-83M | $-44M | $-52M | $-49M | $-18M | · |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% | · | |
| Net Margin | -1136.2% | -651.6% | -721.2% | -732.2% | -898.3% | · | |
| EBITDA Margin | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% | · | |
| ROA | -11.0% | -9.6% | -15.7% | -17.0% | -16.5% | · | |
| ROE | -11.7% | -8.2% | -16.8% | -19.3% | -8.8% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 39.0 | 59.2 | 26.8 | 20.1 | 29.5 | · | |
| Quick Ratio | 38.7 | 58.7 | 26.4 | 19.8 | 29.3 | · |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | · | · | 0.9 | · |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -5.5% | 31.0% | -6.1% | 136.8% | · | · | |
| Revenue CAGR 3Y | 5.1% | 42.8% | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $11M | $8M | $9M | $4M | · | |
| Net Income TTM | $-114M | $-69M | $-58M | $-63M | $-33M | · | |
| Market Cap | $833M | $3.16B | $496M | $548M | $814M | · | |
| P/E | -7.5 | -41.8 | -8.1 | -8.7 | -14.2 | · | |
| P/S | 83.3 | 298.7 | 61.4 | 63.6 | 223.7 | · | |
| P/B | 0.9 | 3.1 | 1.4 | 1.7 | 2.2 | · | |
| P / Tangible Book | 0.9 | 3.1 | 1.4 | 1.7 | 2.2 | · | |
| P / Cash Flow | -10.1 | -72.2 | -9.8 | -12.8 | -47.9 | · | |
| P / FCF | -10.0 | -71.6 | -9.5 | -11.1 | -44.1 | · | |
| Earnings Yield | -13.3% | -2.4% | -12.3% | -11.5% | -7.0% | · |
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $4M | $0 | $10M | $0 | $0 | $0 | $439.0K | $9M | $1M | $3M | $1M | $2M | $2M | $2M | $2M | |
| R&D Expense | $31M | $27M | $32M | $35M | $35M | $25M | $21M | $19M | $15M | $14M | $12M | $15M | $16M | $14M | $14M | $10M | |
| SG&A Expense | $11M | $11M | $11M | $11M | $10M | $10M | $8M | $18M | $8M | $7M | $6M | $7M | $6M | $6M | $6M | $5M | |
| Operating Income | $-32M | $-34M | $-42M | $-35M | $-45M | $-35M | $-29M | $-36M | $-14M | $-20M | $-16M | $-21M | $-20M | $-18M | $-17M | $-14M | |
| Other Non-op | $10M | $10M | $10M | $11M | $11M | $11M | $9M | $8M | $8M | $5M | $4M | $3M | $3M | $1M | $373.0K | $132.0K | |
| Net Income | $-22M | $-24M | $-32M | $-24M | $-34M | $-24M | $-20M | $-28M | $-6M | $-15M | $-12M | $-18M | $-17M | $-17M | $-17M | $-13M | |
| EPS (Basic) | $-0.35 | $-0.39 | $-0.51 | $-0.39 | $-0.55 | $-0.38 | $-0.36 | $-0.51 | $-0.11 | $-0.30 | $-0.25 | $-0.42 | $-0.42 | $-0.40 | $-0.41 | $-0.32 | |
| EPS (Diluted) | $-0.35 | $-0.39 | $-0.51 | $-0.39 | $-0.55 | $-0.38 | $-0.36 | $-0.51 | $-0.11 | $-0.30 | $-0.25 | $-0.42 | $-0.42 | $-0.40 | $-0.41 | $-0.32 | |
| Shares (Basic) | 62,937,295 | 62,665,717 | -123,750,818 | 62,023,685 | 61,902,411 | 61,791,721 | -104,378,597 | 54,628,670 | 54,451,666 | 49,049,741 | 45,708,649 | 41,836,238 | 41,763,971 | 41,526,524 | 41,448,743 | 41,315,482 | |
| Shares (Diluted) | 62,937,295 | 62,665,717 | -123,750,818 | 62,023,685 | 61,902,411 | 61,791,721 | -104,378,597 | 54,628,670 | 54,451,666 | 49,049,741 | 45,708,649 | 41,836,238 | 41,763,971 | 41,526,524 | 41,448,743 | 41,315,482 | |
| EBITDA | $-32M | $-34M | · | $-35M | $-45M | $-35M | · | $-36M | $-14M | $-20M | $-16M | $-21M | $-20M | $-18M | $-17M | $-14M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $52M | $52M | $48M | $52M | $74M | $431M | $27M | $15M | $213M | $17M | $34M | $30M | $65M | $58M | $55M | |
| Short-term Investments | $943M | $905M | $914M | $941M | $944M | $940M | $595M | $631M | $632M | $439M | $333M | $270M | $287M | $274M | $296M | $306M | |
| Receivables | $149.0K | $35M | · | · | · | · | · | · | $8M | $519.0K | $0 | $0 | $750.0K | $500.0K | $0 | $0 | |
| Prepaid Expense | $12M | $11M | $9M | $9M | $10M | $9M | $8M | $8M | $8M | $6M | $5M | $6M | $4M | $5M | $4M | $3M | |
| Current Assets | $983M | $1.00B | $976M | $998M | $1.01B | $1.02B | $1.03B | $666M | $662M | $659M | $355M | $309M | $321M | $344M | $358M | $365M | |
| PP&E (Net) | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $7M | $7M | $7M | $7M | $7M | $4M | $3M | |
| PP&E (Gross) | $11M | $11M | $11M | $11M | $11M | $10M | $10M | $10M | $10M | $10M | $10M | $9M | $9M | $7M | $4M | $3M | |
| Accum. Depreciation | $8M | $7M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $1M | $567.0K | $320.0K | $212.0K | |
| Other Non-current Assets | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $207.0K | $337.0K | |
| Total Assets | $1.01B | $1.03B | $1.00B | $1.02B | $1.03B | $1.05B | $1.06B | $695M | $691M | $689M | $387M | $342M | $353M | $376M | $385M | $369M | |
| Accounts Payable | $3M | $3M | $5M | $3M | $3M | $2M | $4M | $2M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $2M | |
| Accrued Liabilities | $20M | $15M | $18M | $22M | $16M | $13M | $12M | $13M | $9M | $6M | $7M | $9M | $8M | $7M | $4M | $5M | |
| Current Liabilities | $60M | $59M | $25M | $28M | $21M | $18M | $17M | $17M | $12M | $11M | $14M | $18M | $16M | $16M | $13M | $13M | |
| Capital Leases | $18M | $19M | $20M | $20M | $20M | $21M | $21M | $22M | $22M | $23M | $23M | $24M | $24M | $24M | $23M | $0 | |
| Total Liabilities | $80M | $87M | $45M | $48M | $42M | $38M | $39M | $39M | $34M | $33M | $38M | $42M | $42M | $44M | $42M | $13M | |
| Common Stock | $61.0K | $60.0K | $60.0K | $60.0K | $59.0K | $59.0K | $59.0K | $52.0K | $52.0K | $51.0K | $46.0K | $42.0K | $42.0K | $42.0K | $42.0K | $41.0K | |
| Retained Earnings | $-398M | $-376M | $-351M | $-319M | $-295M | $-261M | $-238M | $-218M | $-189M | $-184M | $-157M | $-145M | $-128M | $-94M | $-78M | $-61M | |
| AOCI | $-2M | $576.0K | $4M | $5M | $4M | $4M | $2M | $8M | $-2M | $-524.0K | $-1M | $-1M | $-739.0K | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $928M | $942M | $957M | $977M | $991M | $1.01B | $1.02B | $656M | $658M | $656M | $349M | $299M | $311M | $332M | $344M | $356M | |
| Liabilities + Equity | $1.01B | $1.03B | $1.00B | $1.02B | $1.03B | $1.05B | $1.06B | $695M | $691M | $689M | $387M | $342M | $353M | $376M | $385M | $369M | |
| Shares Outstanding | 61,077,980 | 60,865,458 | 60,384,283 | 60,123,602 | 59,297,814 | 59,168,490 | 59,064,606 | 52,337,239 | 52,162,215 | 51,840,571 | 46,151,427 | 41,867,536 | 41,802,807 | 41,550,704 | 41,501,269 | 41,393,660 |
Cashflow 6
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $10M | $9M | $11M | $11M | $6M | $15M | $6M | $6M | $5M | $6M | $5M | $5M | $4M | $4M | |
| Operating Cash Flow | $12M | $-12M | $-29M | $-13M | $-24M | $-17M | $-17M | $-2M | $-10M | $-15M | $-12M | $-15M | $-14M | $-13M | $-6M | $-12M | |
| CapEx | $202.0K | $273.0K | $106.0K | $93.0K | $473.0K | $371.0K | $42.0K | $25.0K | $95.0K | $197.0K | $470.0K | $580.0K | $285.0K | $3M | $898.0K | $971.0K | |
| Investing Cash Flow | $-39M | $8M | $30M | $8M | $2M | $-340M | $34M | $13M | $-191M | $-114M | $-61M | $18M | $-9M | $20M | $9M | $31M | |
| Financing Cash Flow | $2M | $4M | $3M | $493.0K | $954.0K | $554.0K | $387M | $2M | $3M | $322M | $57M | $528.0K | $2M | $0 | $308.0K | $1.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-17M | · | · | · | $-15M | · | · | $-14M | · | · | $-12M |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -308.7% | -916.5% | · | -352.5% | · | · | · | -8164.5% | -155.4% | -1610.3% | -628.2% | -1962.9% | -990.3% | -994.0% | -729.9% | -852.2% | |
| Net Margin | -214.0% | -652.6% | · | -243.1% | · | · | · | -6391.6% | -67.0% | -1178.9% | -459.6% | -1656.4% | -852.5% | -920.9% | -714.1% | -843.9% | |
| EBITDA Margin | -308.7% | -916.5% | · | -352.5% | · | · | · | -8164.5% | -155.4% | -1610.3% | -628.2% | -1962.9% | -990.3% | -994.0% | -729.9% | -852.2% | |
| ROA | -2.1% | -2.3% | · | -2.8% | -3.9% | -2.7% | · | -5.2% | -1.1% | -2.8% | -3.0% | -4.8% | -4.8% | -4.3% | -4.3% | -7.3% | |
| ROE | -2.3% | -2.5% | · | -3.0% | -4.1% | -2.8% | · | -5.6% | -1.2% | -3.0% | -3.4% | -5.4% | -5.2% | -4.7% | -4.6% | -7.5% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.3 | 17.0 | · | 35.9 | 47.0 | 58.5 | · | 38.8 | 57.3 | 62.1 | 24.5 | 17.3 | 19.9 | 21.1 | 27.6 | 29.1 | |
| Quick Ratio | 16.1 | 16.8 | · | 35.5 | 46.6 | 57.9 | · | 38.3 | 56.6 | 61.5 | 24.2 | 16.9 | 19.7 | 20.8 | 27.3 | 28.9 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 2.7 | 0.2 | · | · | · | · | · | · | 2.4 | 2.0 | 10.1 | · | 5.5 | 7.3 | 12.6 | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24M | $14M | · | $10M | $9M | $11M | · | $13M | $14M | $7M | $7M | $7M | $8M | $7M | $6M | $4M | |
| Net Income TTM | $-105M | $-106M | · | $-110M | $-91M | $-72M | · | $-60M | $-50M | $-61M | $-63M | $-69M | $-64M | $-58M | $-47M | $-33M | |
| Market Cap | $938M | $846M | · | $1.47B | $1.37B | $1.60B | · | $2.38B | $2.19B | $1.95B | $465M | $497M | $506M | $563M | $507M | $594M | |
| P/E | -9.1 | -8.1 | · | -13.4 | -14.9 | -20.8 | · | -38.8 | -38.8 | -27.1 | -6.8 | -7.2 | -7.8 | -9.7 | -7.6 | · | |
| P/S | 39.1 | 61.6 | · | 140.8 | 146.7 | 150.9 | · | 181.4 | 159.2 | 283.9 | 62.6 | 68.2 | 64.7 | 81.2 | 90.6 | 164.4 | |
| P/B | 1.0 | 0.9 | · | 1.5 | 1.4 | 1.6 | · | 3.6 | 3.3 | 3.0 | 1.3 | 1.7 | 1.6 | 1.7 | 1.5 | 1.7 | |
| P / Tangible Book | 1.0 | 0.9 | · | 1.5 | 1.4 | 1.6 | · | 3.6 | 3.3 | 3.0 | 1.3 | 1.7 | 1.6 | 1.7 | 1.5 | 1.7 | |
| P / Cash Flow | · | -68.6 | · | · | · | -93.8 | · | · | · | -131.5 | · | · | -36.4 | · | · | -51.5 | |
| P / FCF | · | -67.1 | · | · | · | -91.8 | · | · | · | -129.8 | · | · | -35.6 | · | · | -47.5 | |
| Earnings Yield | -10.9% | -12.3% | · | -7.5% | -6.7% | -4.8% | · | -2.6% | -2.6% | -3.7% | -14.8% | -13.9% | -12.8% | -10.3% | -13.2% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $10M | $11M | $8M | $9M | $4M |
| Betriebsgewinnmarge % | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% |
| Nettoergebnis | $-114M | $-69M | $-58M | $-63M | $-33M |
| Verwässerte EPS | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 39.0 | 59.2 | 26.8 | 20.1 | 29.5 |
| Quick Ratio | 38.7 | 58.7 | 26.4 | 19.8 | 29.3 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-83M | $-44M | $-52M | $-49M | $-18M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 218 Einreicher · $815.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 46 (+5 vs. Vorquartal) | 28 (0 vs. Vorquartal) | 77 (+9 vs. Vorquartal) | 47 (-5 vs. Vorquartal) | +785K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $171.873.684 | 11.189.693 | 21,07% | Aktien |
| Prosight Management, LP | $58.436.828 | 3.804.481 | 7,17% | Aktien |
| JANUS HENDERSON GROUP PLC | $57.850.010 | 4.165.432 | 7,09% | Aktien |
| STATE STREET CORP | $46.155.249 | 3.004.899 | 5,66% | Aktien |
| VANGUARD GROUP INC | $35.180.174 | 2.549.288 | 4,31% | Aktien |
| Point72 Asset Management, L.P. | $30.625.336 | 1.993.837 | 3,76% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $28.528.911 | 1.857.351 | 3,50% | Aktien |
| TCG Crossover Management, LLC | $27.488.517 | 1.789.617 | 3,37% | Aktien |
| Alyeska Investment Group, L.P. | $25.300.070 | 1.647.140 | 3,10% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20.439.706 | 1.330.710 | 2,51% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $18.543.360 | 1.207.250 | 2,27% | Aktien |
| FMR LLC | $18.439.419 | 1.200.483 | 2,26% | Aktien |
| ALGERT GLOBAL LLC | $17.063.255 | 1.110.889 | 2,09% | Aktien |
| D. E. Shaw & Co., Inc. | $16.842.378 | 1.096.509 | 2,07% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $16.009.820 | 1.042.306 | 1,96% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $15.824.854 | 1.030.000 | 1,94% | Aktien |
| GOLDMAN SACHS GROUP INC | $12.850.084 | 836.594 | 1,58% | Aktien |
| Nantahala Capital Management, LLC | $12.440.279 | 809.914 | 1,53% | Aktien |
| BANK OF AMERICA CORP /DE/ | $11.710.018 | 762.371 | 1,44% | Aktien |
| Qube Research & Technologies Ltd | $10.783.596 | 702.057 | 1,32% | Aktien |
| Squarepoint Ops LLC | $8.176.451 | 532.321 | 1,00% | Aktien |
| ORBIMED ADVISORS LLC | $8.059.392 | 524.700 | 0,99% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.749.796 | 504.544 | 0,95% | Aktien |
| ADAR1 Capital Management, LLC | $6.464.732 | 420.881 | 0,79% | Aktien |
| Cubist Systematic Strategies, LLC | $6.293.960 | 257.527 | 0,77% | Aktien |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $5.782.979 | 376.496 | 0,71% | Aktien |
| Woodline Partners LP | $5.683.692 | 370.032 | 0,70% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $5.670.774 | 369.191 | 0,70% | Aktien |
| Rock Springs Capital Management LP | $5.637.258 | 367.009 | 0,69% | Aktien |
| Jump Financial, LLC | $5.555.174 | 361.665 | 0,68% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $5.393.265 | 351.124 | 0,66% | Aktien |
| BlackRock, Inc. | $5.070.812 | 330.131 | 0,62% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $4.842.563 | 315.271 | 0,59% | Aktien |
| CITADEL ADVISORS LLC | $4.480.497 | 291.699 | 0,55% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $4.133.576 | 269.113 | 0,51% | Aktien |
| Man Group plc | $3.821.583 | 248.801 | 0,47% | Aktien |
| Balyasny Asset Management L.P. | $3.250.714 | 211.635 | 0,40% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $3.219.348 | 209.593 | 0,39% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $3.018.040 | 196.487 | 0,37% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.403.840 | 156.500 | 0,29% | Verkaufsoption |
| BML Capital Management, LLC | $2.380.201 | 154.961 | 0,29% | Aktien |
| Springhill Fund Asset Management (HK) Co Ltd | $2.119.500 | 78.500 | 0,26% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $2.018.565 | 131.417 | 0,25% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.744.896 | 113.600 | 0,21% | Kaufoption |
| FEDERATED HERMES, INC. | $1.719.537 | 111.949 | 0,21% | Aktien |
| CAPITAL FUND MANAGEMENT S.A. | $1.566.289 | 101.972 | 0,19% | Aktien |
| Rangeley Capital, LLC | $1.504.942 | 97.978 | 0,18% | Aktien |
| TWO SIGMA ADVISERS, LP | $1.436.580 | 104.100 | 0,18% | Aktien |
| WINTON GROUP Ltd | $1.387.008 | 90.300 | 0,17% | Aktien |
| AVALON VENTURES MANAGEMENT, LLC | $1.302.652 | 53.300 | 0,16% | Aktien |
| Swiss National Bank | $1.218.048 | 79.300 | 0,15% | Aktien |
| XTX Topco Ltd | $1.186.299 | 77.233 | 0,15% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1.177.000 | 76.601 | 0,14% | Aktien |
| JANE STREET GROUP, LLC | $1.167.252 | 75.993 | 0,14% | Aktien |
| JANE STREET GROUP, LLC | $1.165.824 | 75.900 | 0,14% | Kaufoption |
| Quantinno Capital Management LP | $1.078.840 | 70.237 | 0,13% | Aktien |
| CITIGROUP INC | $1.040.486 | 67.740 | 0,13% | Aktien |
| CONGRESS ASSET MANAGEMENT CO | $1.038.490 | 67.610 | 0,13% | Aktien |
| Trexquant Investment LP | $973.133 | 63.355 | 0,12% | Aktien |
| Walleye Capital LLC | $957.512 | 62.338 | 0,12% | Aktien |
| Raiffeisen Bank International AG | $919.500 | 60.000 | 0,11% | Aktien |
| BARCLAYS PLC | $899.528 | 58.563 | 0,11% | Aktien |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $860.160 | 56.000 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $848.184 | 55.221 | 0,10% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $847.344 | 60.960 | 0,10% | Aktien |
| Rafferty Asset Management, LLC | $823.419 | 53.608 | 0,10% | Aktien |
| Bank of New York Mellon Corp | $780.595 | 50.820 | 0,10% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $749.169 | 48.774 | 0,09% | Aktien |
| HighVista Strategies LLC | $743.056 | 48.376 | 0,09% | Aktien |
| AXQ CAPITAL, LP | $729.723 | 47.508 | 0,09% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $713.871 | 46.476 | 0,09% | Aktien |
| Engineers Gate Manager LP | $696.008 | 45.313 | 0,09% | Aktien |
| HSBC HOLDINGS PLC | $686.212 | 44.101 | 0,08% | Aktien |
| DEUTSCHE BANK AG\ | $664.750 | 43.278 | 0,08% | Aktien |
| Jain Global LLC | $636.349 | 41.429 | 0,08% | Aktien |
| Verdad Advisers, LP | $620.329 | 40.386 | 0,08% | Aktien |
| Schonfeld Strategic Advisors LLC | $616.871 | 40.161 | 0,08% | Aktien |
| CITADEL ADVISORS LLC | $589.824 | 38.400 | 0,07% | Kaufoption |
| FRANKLIN RESOURCES INC | $577.060 | 37.569 | 0,07% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $514.314 | 37.001 | 0,06% | Aktien |
| TEMA ETFS LLC | $511.870 | 37.092 | 0,06% | Aktien |
| MARSHALL WACE, LLP | $502.794 | 32.734 | 0,06% | Aktien |
| MARTINGALE ASSET MANAGEMENT L P | $475.807 | 30.977 | 0,06% | Aktien |
| Hudson Bay Capital Management LP | $460.800 | 30.000 | 0,06% | Aktien |
| Walleye Capital LLC | $459.264 | 29.900 | 0,06% | Kaufoption |
| CenterBook Partners LP | $437.791 | 28.502 | 0,05% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $431.155 | 28.070 | 0,05% | Aktien |
| PROFUND ADVISORS LLC | $414.305 | 26.973 | 0,05% | Aktien |
| Entropy Technologies, LP | $411.571 | 26.795 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $399.836 | 26.031 | 0,05% | Aktien |
| CITADEL ADVISORS LLC | $394.752 | 25.700 | 0,05% | Verkaufsoption |
| VANGUARD ASSET MANAGEMENT, Ltd | $375.383 | 24.439 | 0,05% | Aktien |
| Virtus Investment Advisers, LLC | $370.637 | 24.130 | 0,05% | Aktien |
| Point72 (DIFC) Ltd | $370.046 | 15.141 | 0,05% | Aktien |
| Aigen Investment Management, LP | $350.838 | 22.841 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $305.818 | 19.910 | 0,04% | Aktien |
| Bleakley Financial Group, LLC | $305.649 | 19.899 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $303.805 | 19.779 | 0,04% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $302.362 | 19.685 | 0,04% | Aktien |
| Lion Point Capital, LP | $291.840 | 19.000 | 0,04% | Aktien |
Unternehmensinsider 21 Insider · 9 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| David Alan Campbell | President and CEO | 31. Juli 2026 G | 264.742 | 0 | 0 | $0 |
| Tighe Reardon | Acting Chief Financial Officer | 2. Januar 2024 A | 849.854 | 0 | 0 | $0 |
| Janeen Noel Doyle | Chief Corp. & Bus. Dev. Ofcr | 2. Juni 2026 S | 75.941 | 0 | 1 | $-56.944 |
| Thomas Diraimondo | Chief Scientific Officer | 2. Januar 2024 A | — | 0 | 0 | $0 |
| Charles M. Winter | Chief Technical Officer | 2. Januar 2024 A | — | 0 | 0 | $0 |
| Byron Robinson | Chief Strategy Officer | 2. Januar 2024 A | — | 0 | 0 | $0 |
| Andrew Hollman Meyer | Chief Business Officer | 2. Januar 2024 A | — | 0 | 0 | $0 |
| Wayne Godfrey | Chief Medical Officer | 3. Januar 2023 A | — | 0 | 0 | $0 |
| Shahram Salek-Ardakani | Chief Scientific Officer | 3. Januar 2022 A | — | 0 | 0 | $0 |
| Jake Simson | Direktor | 11. Juni 2026 A | 11.750 | 0 | 0 | $0 |
| Natasha Hernday | Direktor | 11. Juni 2026 A | 15.481 | 0 | 0 | $0 |
| Winston Kung | Direktor | 11. Juni 2026 A | 11.750 | 0 | 0 | $0 |
| Ronald W Barrett | Direktor | 11. Juni 2026 A | 11.750 | 0 | 0 | $0 |
| Vickie L Capps | Direktor | 11. Juni 2026 A | 79.598 | 0 | 0 | $0 |
| Eric Dobmeier | Direktor | 11. Juni 2026 A | 15.481 | 0 | 0 | $0 |
| Jay Lichter | Direktor | 13. November 2023 P | 849.854 | 0 | 0 | $0 |
| Alana B. Mcnulty | Direktor | 14. Juni 2023 A | — | 0 | 0 | $0 |
| Sheila Gujrathi | Direktor | 14. Juni 2023 A | — | 0 | 0 | $0 |
| Stefan Heller | Direktor | 14. Juni 2022 A | — | 0 | 0 | $0 |
| Peter A. Thompson | Direktor | 14. Juni 2022 A | 231.098 | 0 | 0 | $0 |
| Bregua Corp | 10%-Eigentümer | 15. Juni 2021 C | 3.749.250 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 Einreichungen | 10. März 2025 | 19,90% | Änderung | — | SEC |
| Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P., Avalon BioVentures I, LP, Avalon Ventures XI GP LLC, ABV SPV I GP LLC, Avalon BioVentures GP, LLC, Kevin Kinsella, Richard Levandov, Braden Bohrmann, Jay Lichter, Ph.D., Tighe Reardon, Sergio G. Duron, Ph.D., Sanford Madigan, Ph.D. ×6 Einreichungen | 8. November 2024 | — | Erste Einreichung | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VIII LLC, OrbiMed Genesis GP LLC, OrbiMed Capital LLC ×3 Einreichungen | 9. August 2024 | — | Erste Einreichung | — | SEC |
| Avalon Ventures XI, L.P. (“Avalon Ventures”), Avalon BioVentures SPV I, L.P. (“ABV SPV”), Avalon Bioventures I, LP (“ABV I”), Avalon Ventures XI GP LLC (“Avalon XI GP”), ABV SPV I GP LLC (“ABV SPV GP”), Avalon BioVentures GP, LLC (“ABV GP”), Kevin Kinsella (“Kinsella”), Richard Levandov (“Levandov”), Braden Bohrmann (“Bohrmann”), Jay Lichter, Ph.D. (“Lichter”), Tighe Reardon (“Reardon”), Sergio Duron (“Duron”), Sanford Madigan, Ph.D. (“Madigan”) ×2 Einreichungen | 16. November 2023 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 41 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IDNA · iShares Trust | 1,01% | 124.166 SH | 8. August 2026 | Täglich |
| BBC · ETFis Series Trust I | 0,69% | 18.038 NS | 30. April 2026 | N-PORT |
| CANC · Tema ETF Trust | 0,43% | 51.522 NS | 31. Mai 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 0,42% | 11.754 NS | 31. Mai 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,33% | 62.348 NS | 31. Mai 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,23% | 81.512 NS | 30. April 2026 | N-PORT |
| ESSC · Strategy Shares | 0,12% | 2.106 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 0,07% | 423.011 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 3.319 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,04% | 2.251 NS | 31. Mai 2026 | N-PORT |
| IWN · iShares Trust | 0,04% | 401.400 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 37.644 SH | 8. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 14.865 NS | 30. April 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 9.972 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 1.104.928 SH | 8. August 2026 | Täglich |
| SMLF · iShares Trust | 0,02% | 53.265 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 248.060 SH | 8. August 2026 | Täglich |
| TECB · iShares Trust | 0,02% | 5.624 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 18.584 NS | 30. April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 31.889 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,02% | 2.017 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 28.040 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 229.332 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 2.013 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 552.164 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 117.899 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,01% | 1.578 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 17.660 NS | 30. April 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 1.594 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 62.209 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2.543 SH | 8. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 1.318 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.827 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 40 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 68.791 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 13.511 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 27.817 NS | 31. Mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 154 NS | 30. April 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 696 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.263.837 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.110 SH | 8. August 2026 | Täglich |